Predictors of treatment with osteoporosis medications after recent fragility fractures in a multinational cohort of postmenopausal women.
about
Identification and management of patients at increased risk of osteoporotic fracture: outcomes of an ESCEO expert consensus meetingCharacteristics associated with anti-osteoporosis medication use: data from the Global Longitudinal Study of Osteoporosis in Women (GLOW) USA cohort.Osteoporosis treatment disparities: a 6-year aggregate analysis from national survey data.Geriatric Hip Fracture Care: Fixing a Fragmented System.Quality of osteoporosis care of older Medicare recipients with fragility fractures: 2006 to 2010.Systematic review of raloxifene in postmenopausal Japanese women with osteoporosis or low bone mass (osteopenia).Patterns of anti-osteoporosis medication use among women at high risk of fracture: findings from the Global Longitudinal Study of Osteoporosis in Women (GLOW).Undertreatment of osteoporosis and the role of gastrointestinal events among elderly osteoporotic women with Medicare Part D drug coverage.Intrinsic mechanical behavior of femoral cortical bone in young, osteoporotic and bisphosphonate-treated individuals in low- and high energy fracture conditionsCapture the Fracture: a Best Practice Framework and global campaign to break the fragility fracture cycle.Long-term effects of bisphosphonate therapy: perforations, microcracks and mechanical properties.Best practices in secondary fracture prevention: fracture liaison services.Use of calcium supplements, vitamin D supplements and specific osteoporosis drugs among French women aged 75-85 years: patterns of use and associated factors.Insights from the Global Longitudinal Study of Osteoporosis in Women (GLOW).Reprint of: The impact of fragility fracture and approaches to osteoporosis risk assessment worldwide.The impact of fragility fracture and approaches to osteoporosis risk assessment worldwide.Self-perception of fracture risk: what can it tell us?A Survey of Women's Awareness of and Reasons for Lack of Postfracture Osteoporotic Care.Disparities in osteoporosis treatments.Addressing the Crisis in the Treatment of Osteoporosis: A Path Forward.PREVALENCE OF OSTEOPOROSIS AND HYPOVITAMINOSIS D AT SIRIRAJ METABOLIC BONE DISEASE CLINIC.Hearing impairment increases the risk of distal radius, hip, and spine fractures: A longitudinal follow-up study using a national sample cohort.Consensus statement: osteoporosis prevention and treatment in Latin America-current structure and future directions
P2860
Q30234621-897277DA-E449-4421-A495-20B107C2E3C0Q30564085-89C3B151-21DA-47B4-B037-5E861203199AQ30829086-A177A672-12A8-4246-BF7D-DB5DB55B941CQ33655830-243538E3-6ACC-4B74-BCE0-96DC417E9C84Q33854982-2A715597-9B6D-481D-B318-A5370F6138FAQ34482507-7F700DC8-6552-40FA-9786-6C8E6609B14DQ35077750-6F85F4BC-6CA3-4E03-86A0-8EE5A91C9121Q36265141-6AFB27AE-0259-4318-AD80-353391F2654DQ36583064-6FA14ED0-34FA-47A6-9DED-D5976CE88BEEQ36997750-4F7CEFE0-EDE2-4088-B9AE-147CDAAA4919Q37682081-8DD90344-7DA5-4842-A7C1-D763EFEED24AQ38075460-8689D1F9-45D7-460B-93F7-C9B93D50916FQ38151572-8E0B7114-CB37-45D4-8CD4-4DDE9CE214D1Q38206066-C41AB6CF-3FFE-4ABE-8E7F-B558FE17B02AQ38402233-873EDC2E-2E99-4F5D-A074-D7713AE33070Q38406462-16B8B6BC-4B67-4CFB-9863-BB817E5660E5Q38598416-402D52F6-2E93-4FC3-A5B6-3347F9FDE38CQ38728444-F547B767-B7CC-4E05-A937-CCA008DBB369Q38980554-AC6301D2-5B6B-45A6-BA87-DA54DADFC1F9Q39014377-8D7C474C-2DCF-4E92-B438-41283DA0C691Q49632954-A958FCD6-4229-41B1-B2FB-4757C8F1224FQ50041801-07EAEC11-84A6-44E1-87BF-A2F22D536499Q57167564-E7925C29-52B9-456D-B4C5-91A948522786
P2860
Predictors of treatment with osteoporosis medications after recent fragility fractures in a multinational cohort of postmenopausal women.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 08 February 2012
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Predictors of treatment with o ...... ohort of postmenopausal women.
@en
Predictors of treatment with o ...... ohort of postmenopausal women.
@nl
type
label
Predictors of treatment with o ...... ohort of postmenopausal women.
@en
Predictors of treatment with o ...... ohort of postmenopausal women.
@nl
prefLabel
Predictors of treatment with o ...... ohort of postmenopausal women.
@en
Predictors of treatment with o ...... ohort of postmenopausal women.
@nl
P2093
P2860
P1476
Predictors of treatment with o ...... ohort of postmenopausal women.
@en
P2093
Allison Wyman
Andrea Z Lacroix
Ethel S Siris
Frederick A Anderson
Frederick H Hooven
J Coen Netelenbos
Johannes Pfeilschifter
Nelson B Watts
Robert Lindsay
Silvano Adami
P2860
P304
P356
10.1111/J.1532-5415.2011.03854.X
P407
P577
2012-02-08T00:00:00Z